TuHURA Biosciences (HURA) borrows additional $1.5M under $50M loan facility
Rhea-AI Filing Summary
TuHURA Biosciences, Inc. reports the creation of a direct financial obligation through an additional borrowing under its existing Loan Agreement with Parkview Holdings One LLC. The agreement provides for a revolving credit facility with a maximum availability of $50 million, maturing on April 21, 2031.
On July 28, 2026, the company drew an additional $1,500,000 under this facility and expects to use the proceeds for general corporate purposes. Management highlights risks related to its ability to meet conditions for future drawdowns, the sufficiency of available funds, and potential conflicts of interest because the lender is an affiliate of the company’s largest stockholder.
Positive
- None.
Negative
- None.
Filing Explained
Against cash and equivalents of
Sources and calculations
- TuHURA Biosciences Form 8-K (2026-07-29)
- TuHURA Biosciences latest quarterly fundamentals (2026Q3)
- Cash and equivalents vs quarterly operating cash outflow, in days of cash use $6,298,127 / ($4,412,953 / 90) = [object Object]
8-K Event Classification
2 items: 2.03, 9.01
2 items
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Revolving credit facility limit: $50 million
New borrowing: $1,500,000
Facility maturity date: April 21, 2031
3 metrics
Revolving credit facility limit
$50 million
Maximum amount of loan availability under the Loan Agreement
New borrowing
$1,500,000
Additional draw under the revolving credit facility on July 28, 2026
Facility maturity date
April 21, 2031
Maturity of the revolving credit facility with Parkview Holdings One LLC
Key Terms
revolving credit facility, off-balance sheet arrangement, forward-looking statements, emerging growth company, +1 more
5 terms
revolving credit facility financial
"provides for a revolving credit facility that matures on April 21, 2031"
A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.
off-balance sheet arrangement financial
"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement"
An off-balance sheet arrangement is a financial commitment or asset that a company keeps out of its main financial statements so it does not show up as a direct asset or liability. Think of it like renting equipment or using a separate storage locker instead of putting the item in your home: the economic effects exist, but they aren’t listed on the company’s primary balance sheet. Investors care because these arrangements can hide risks, obligations or sources of cash flow that affect a company’s true financial strength and future performance.
forward-looking statements regulatory
"contains certain “forward-looking statements” within the meaning of"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
largest stockholder financial
"affiliate of the Company’s largest stockholder"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What new debt did TuHURA Biosciences (HURA) incur in this report?
TuHURA Biosciences incurred a new direct financial obligation by borrowing an additional $1,500,000 under its existing revolving credit facility. This additional draw was made on July 28, 2026 and is part of a broader $50 million credit line.
What is the size and maturity of TuHURA Biosciences (HURA) credit facility?
The Loan Agreement provides a revolving credit facility with up to $50 million in loan availability. The facility matures on April 21, 2031, giving the company a multi‑year source of potential borrowing capacity for its operations and development activities.
How will TuHURA Biosciences (HURA) use the additional $1.5 million it borrowed?
The company states that the additional $1,500,000 draw under the revolving credit facility is expected to be used for general corporate purposes. This broad category typically includes operating expenses, development programs, and other routine corporate funding needs.
Who is the lender under TuHURA Biosciences (HURA) Loan Agreement?
The lender under the Loan Agreement is Parkview Holdings One LLC. The company notes that the loan involves an affiliate of its largest stockholder, which it identifies as a potential source of conflicts of interest in its risk disclosures.
What key risks does TuHURA Biosciences (HURA) associate with this Loan Agreement?
Key risks include the possibility of failing to satisfy conditions for further drawdowns, the chance that available funds may be insufficient for operations and development, and potential conflicts of interest because the lender is affiliated with the company’s largest stockholder.
Does TuHURA Biosciences (HURA) discuss its need for additional capital?
Yes. The company’s forward‑looking statements reference its needs and expectations regarding existing and future capital resources and expenses, and its need for additional capital, indicating that ongoing funding requirements remain an important consideration for its business.